- Home
- RZLV vs ANGO Comparison
RZLV vs ANGO Comparison
Compare RZLV & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLV
- ANGO
- Stock Information
- Founded
- RZLV 2016
- ANGO 1988
- Country
- RZLV United Kingdom
- ANGO United States
- Employees
- RZLV N/A
- ANGO N/A
- Industry
- RZLV
- ANGO Medical/Dental Instruments
- Sector
- RZLV
- ANGO Health Care
- Exchange
- RZLV NYSE
- ANGO Nasdaq
- Market Cap
- RZLV 474.9M
- ANGO 401.4M
- IPO Year
- RZLV N/A
- ANGO 2004
- Fundamental
- Price
- RZLV $1.30
- ANGO $9.66
- Analyst Decision
- RZLV Strong Buy
- ANGO Strong Buy
- Analyst Count
- RZLV 5
- ANGO 3
- Target Price
- RZLV $5.20
- ANGO $13.00
- AVG Volume (30 Days)
- RZLV 2.8M
- ANGO 498.8K
- Earning Date
- RZLV 02-21-2025
- ANGO 04-02-2025
- Dividend Yield
- RZLV N/A
- ANGO N/A
- EPS Growth
- RZLV N/A
- ANGO N/A
- EPS
- RZLV N/A
- ANGO N/A
- Revenue
- RZLV $151,686.00
- ANGO $286,498,000.00
- Revenue This Year
- RZLV $82.13
- ANGO N/A
- Revenue Next Year
- RZLV $12,858.59
- ANGO $6.63
- P/E Ratio
- RZLV N/A
- ANGO N/A
- Revenue Growth
- RZLV 25.96
- ANGO N/A
- 52 Week Low
- RZLV $1.19
- ANGO $5.47
- 52 Week High
- RZLV $14.50
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- RZLV N/A
- ANGO 48.61
- Support Level
- RZLV N/A
- ANGO $9.34
- Resistance Level
- RZLV N/A
- ANGO $10.29
- Average True Range (ATR)
- RZLV 0.00
- ANGO 0.40
- MACD
- RZLV 0.00
- ANGO 0.05
- Stochastic Oscillator
- RZLV 0.00
- ANGO 52.99
About RZLV REZOLVE AI LTD
Rezolve AI Ltd provides a mobile commerce and engagement platform, underpinned by machine learning, that enables retailers, brands and manufacturers to engage with consumers in a broad range of locations and settings via their mobile devices and personal computers. its platform allows for mobile engagement with merchants using its software to extend their business to consumers' mobile devices and computers in different ways.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.